Final thoughts: Are GLP-1 agonists medications worth it
Many clinicians consider anti-obesity medications after the initial rapid weight loss phase, typically 6-12 months post-operatively, or when patients experience a plateau or weight regain despite adherence to post-surgical recommendations
For most women, the first signs that its working arent on the scale theyre in your energy, your cravings, and your mood
Once reconstituted, peptides must remain refrigerated at 28C and used within their stability window (2128 days)
IQVIA data shows that as of Q1 2025, Eli Lilly (including tirzepatide, dulaglutide and other related products) has increased its total prescription volume in the US incretin analog market to 53.3%, surpassing its main competitor, Novo Nordisk
The receptors for GLP-1 are more ubiquitous, and the drugs have more widespread actions